Pfizer expects $54 billion in 2022 sales on Covid vaccine and treatment pill

Pfizer expects to sell $32 billion of its Covid-19 shots and $22 billion of its antiviral coronavirus treatment pill Paxlovid.

from Health and Science https://ift.tt/Nb3fPA0
https://ift.tt/HVwpivm
https://ift.tt/Uy8bQ5A